Share-based Payment Arrangement, Expense of PROKIDNEY CORP. from 31 Dec 2020 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
- Summary
-
PROKIDNEY CORP. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
- PROKIDNEY CORP. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $5,705,000, a 18% decline year-over-year.
- PROKIDNEY CORP. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $25,336,000, a 14% decline year-over-year.
- PROKIDNEY CORP. annual Share-based Payment Arrangement, Expense for 2025 was $25,336,000, a 14% decline from 2024.
- PROKIDNEY CORP. annual Share-based Payment Arrangement, Expense for 2024 was $29,372,000, a 4.8% decline from 2023.
- PROKIDNEY CORP. annual Share-based Payment Arrangement, Expense for 2023 was $30,846,000, a 59% decline from 2022.
- Source SEC data
- View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)
PROKIDNEY CORP. Quarterly Share-based Payment Arrangement, Expense (USD)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $25,336,000 | $5,705,000 | -$1,245,000 | -18% | 01 Oct 2025 | 31 Dec 2025 | 10-K | 18 Mar 2026 | 2025 | FY |
| Q3 2025 | $26,581,000 | $6,675,000 | -$259,000 | -3.7% | 01 Jul 2025 | 30 Sep 2025 | 10-Q | 10 Nov 2025 | 2025 | Q3 |
| Q2 2025 | $26,840,000 | $6,540,000 | -$1,268,000 | -16% | 01 Apr 2025 | 30 Jun 2025 | 10-Q | 12 Aug 2025 | 2025 | Q2 |
| Q1 2025 | $28,108,000 | $6,416,000 | -$1,264,000 | -16% | 01 Jan 2025 | 31 Mar 2025 | 10-Q | 12 May 2025 | 2025 | Q1 |
| Q4 2024 | $29,372,000 | $6,950,000 | +$13,319,000 | 01 Oct 2024 | 31 Dec 2024 | 10-K | 18 Mar 2026 | 2025 | FY | |
| Q3 2024 | $16,053,000 | $6,934,000 | -$6,059,000 | -47% | 01 Jul 2024 | 30 Sep 2024 | 10-Q | 10 Nov 2025 | 2025 | Q3 |
| Q2 2024 | $22,112,000 | $7,808,000 | -$3,394,000 | -30% | 01 Apr 2024 | 30 Jun 2024 | 10-Q | 12 Aug 2025 | 2025 | Q2 |
| Q1 2024 | $25,506,000 | $7,680,000 | -$5,340,000 | -41% | 01 Jan 2024 | 31 Mar 2024 | 10-Q | 12 May 2025 | 2025 | Q1 |
| Q4 2023 | $30,846,000 | $6,369,000 | -$15,308,000 | -171% | 01 Oct 2023 | 31 Dec 2023 | 10-K | 18 Mar 2026 | 2025 | FY |
| Q3 2023 | $46,154,000 | $12,993,000 | +$8,149,000 | +168% | 01 Jul 2023 | 30 Sep 2023 | 10-Q | 12 Nov 2024 | 2024 | Q3 |
| Q2 2023 | $38,005,000 | $11,202,000 | +$3,202,000 | +40% | 01 Apr 2023 | 30 Jun 2023 | 10-Q | 09 Aug 2024 | 2024 | Q2 |
| Q1 2023 | $34,803,000 | $13,020,000 | -$39,666,000 | -75% | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 10 May 2024 | 2024 | Q1 |
| Q4 2022 | $74,469,000 | $8,939,000 | 01 Oct 2022 | 31 Dec 2022 | 10-K | 17 Mar 2025 | 2024 | FY | ||
| Q3 2022 | $4,844,000 | +$4,844,000 | 01 Jul 2022 | 30 Sep 2022 | 10-Q | 14 Nov 2023 | 2023 | Q3 | ||
| Q2 2022 | $8,000,000 | 01 Apr 2022 | 30 Jun 2022 | 10-Q | 10 Aug 2023 | 2023 | Q2 | |||
| Q1 2022 | $52,686,000 | 01 Jan 2022 | 31 Mar 2022 | 10-Q | 11 May 2023 | 2023 | Q1 | |||
| Q3 2021 | $0 | 30 Sep 2021 | 10-Q | 15 Nov 2021 | 2021 | Q3 | ||||
| Q3 2021 | $175,000 | 01 Jul 2021 | 30 Sep 2021 | 10-Q | 14 Nov 2022 | 2022 | Q3 |
PROKIDNEY CORP. Annual Share-based Payment Arrangement, Expense (USD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $25,336,000 | -$4,036,000 | -14% | 01 Jan 2025 | 31 Dec 2025 | 10-K | 18 Mar 2026 | 2025 | FY |
| 2024 | $29,372,000 | -$1,474,000 | -4.8% | 01 Jan 2024 | 31 Dec 2024 | 10-K | 18 Mar 2026 | 2025 | FY |
| 2023 | $30,846,000 | -$43,623,000 | -59% | 01 Jan 2023 | 31 Dec 2023 | 10-K | 18 Mar 2026 | 2025 | FY |
| 2022 | $74,469,000 | +$73,770,000 | +10554% | 01 Jan 2022 | 31 Dec 2022 | 10-K | 17 Mar 2025 | 2024 | FY |
| 2021 | $699,000 | -$31,000 | -4.2% | 01 Jan 2021 | 31 Dec 2021 | 10-K | 22 Mar 2024 | 2023 | FY |
| 2020 | $730,000 | 01 Jan 2020 | 31 Dec 2020 | 10-K | 28 Mar 2023 | 2022 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.